Adipocyte secreted NRG4 ameliorates age-associated metabolic dysfunction
Liwei Chen, Xuan Ye, Yangyang Zhu, Jinghui Wang, Wen Tian, Xiaoyue Yang, Wei Chen, Si Chen, Si-Yi Wang, Qizeng Miao, Yahui Liu, Rong Zhang, Cheng Hu, Yi Zhang, Jin Li, Haoyong Yu
Abstract
With the progressive aging of society, there is an increasing prevalence of age-related diseases that pose a threat to the elderly's quality of life. Adipose tissue, a vital energy reservoir with endocrine functions, is one of the most vulnerable tissues in aging, which in turn influences systematic aging process, including metabolic dysfunction. However, the underlying mechanism is still poorly understood. In this study, we found that NRG4, a novel adipokine, is obviously decreased in adipocyte tissues and serums during aging. Moreover, delivered recombinant NRG4 protein (rNRG4) into aged mice can ameliorate age-associated insulin resistance, glucose disorders and other metabolic disfunction. In addition, rNRG4 treatment alleviates age-associated hepatic steatosis and sarcopenia, accompanied with altered gene signatures. Together, these results indicate that NRG4 plays a key role in the aging process and is a therapeutic target for the treatment of age-associated metabolic dysfunction.